136 related articles for article (PubMed ID: 34266319)
1. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
[TBL] [Abstract][Full Text] [Related]
2. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
3. Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
Wang X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Zhang A; Shen D; Zheng C; Qi J; Zhao D; Shi J; Jin L; Rao J; Zhang W
Oncotarget; 2017 Apr; 8(15):24892-24901. PubMed ID: 28206963
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of macrophage inhibitory cytokine 1 as a novel prognostic biomarkers for early gastric cancer screening.
Ge X; Zhang X; Ma Y; Chen S; Chen Z; Li M
J Clin Lab Anal; 2021 Jan; 35(1):e23568. PubMed ID: 32918498
[TBL] [Abstract][Full Text] [Related]
5. Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer.
Qiu S; Nikolaou S; Fiorentino F; Rasheed S; Darzi A; Cunningham D; Tekkis P; Kontovounisios C
Horm Cancer; 2019 Jun; 10(2-3):128-135. PubMed ID: 31093954
[TBL] [Abstract][Full Text] [Related]
6. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
7. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.
Wang X; Li Y; Tian H; Qi J; Li M; Fu C; Wu F; Wang Y; Cheng D; Zhao W; Zhang C; Wang T; Rao J; Zhang W
BMC Cancer; 2014 Aug; 14():578. PubMed ID: 25106741
[TBL] [Abstract][Full Text] [Related]
9. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.
Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X
Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262
[TBL] [Abstract][Full Text] [Related]
12. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
[TBL] [Abstract][Full Text] [Related]
13. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
14. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
[TBL] [Abstract][Full Text] [Related]
15. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
Rao H; Wu H; Huang Q; Yu Z; Zhong Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
[TBL] [Abstract][Full Text] [Related]
16. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
17. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
18. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.
Sugimoto M; Takagi T; Konno N; Suzuki R; Asama H; Watanabe K; Nakamura J; Waragai Y; Kikuchi H; Takasumi M; Sato Y; Hikichi T; Ohira H
Sci Rep; 2017 Aug; 7(1):9198. PubMed ID: 28835660
[TBL] [Abstract][Full Text] [Related]
20. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
